Abivax discloses JPMorgan beneficial stake at 4.86%
Jpmorgan Chase
Abivax SA Sponsored ADR
Jpmorgan Chase JPM | 0.00 | |
Abivax SA Sponsored ADR ABVX | 0.00 |
- JPMorgan Chase cut its stake in Abivax below 5% on June 23, holding 3,731,313 shares, equal to 4.68% of capital.
- The bank moved back above 5% on June 24, reporting 4,277,848 shares, equal to 5.36% of capital.
- JPMorgan again fell below 5% on June 25, reporting 3,881,327 shares, equal to 4.86% of capital.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abivax SA published the original content used to generate this news brief on June 30, 2026, and is solely responsible for the information contained therein.
